Recent Updates
Recently added Catalysts
AMGN Positive Sentiment Score: 70/100

AMGEN TO PRESENT AT THE 44TH ANNUAL TD COWEN HEALTH CARE CONFERENCE Amgen (NASDAQ:AMGN) will present at the 44th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Tuesday, March 5, 2024. Peter Griffith,...

Key Takeaway: Amgen (NASDAQ: AMGN) announced its participation at the 44th Annual TD Cowen Health Care Conference scheduled for March 5, 2024. Executive Vice President Peter Griffith and Chief Medical Officer Paul Burton will represent the company, presenting the latest developments in their business. The event will include a webcast available to the media, investors, and the general public, with archived access for 90 days post-event. This highlights Amgen's commitment to transparency and investor engagement in the biotech sector.

Market Sentiment Analysis

POSITIVE FACTORS

  • Amgen will present at a significant industry conference, enhancing visibility.
  • Peter Griffith and Paul Burton's participation highlights engagement of top executives.
  • The event open to public showcases transparency and investor relations commitment.

Full Press Release Details

THOUSAND OAKS, Calif. , Feb. 29, 2024 /PRNewswire/ -- Amgen (NASDAQ: AMGN ) will present at the 44 th Annual TD Cowen Health Care Conference at 9:10 a.m. ET on Tuesday , March 5, 2024. Peter Griffith , executive vice president and chief financial officer at Amgen, and Paul Burton , senior vice president and chief medical officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.
The webcast, as with other selected presentations regarding developments in Amgen's business given by management at certain investor and medical conferences, can be found on Amgen's website, www.amgen.com , under Investors. Information regarding presentation times, webcast availability and webcast links are noted on Amgen's Investor Relations Events Calendar. The webcast will be archived and available for replay for at least 90 days after the event.
Additional Information on Amgen.com To provide further context, information and detail around our activities with respect to our obesity program, Amgen has established a website called "Amgen Perspectives in Obesity". Click here for more information: www.Amgen.com/obesity .
About Amgen Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.
Amgen is one of the 30 companies that comprise the Dow Jones Industrial Average and is also part of the Nasdaq-100 index. In 2023, Amgen was named one of "America's Greatest Workplaces" by Newsweek, one of "America's Climate Leaders" by USA Today and one of the "World's Best Companies" by TIME.
CONTACT: Amgen, Thousand Oaks Jessica Akopyan , 805-440-5721 (media) Justin Claeys , 805-313-9775 (investors)

21 %

Frequently Asked Questions

When will Amgen present at the TD Cowen Health Care Conference?

Amgen will present on March 5, 2024, at 9:10 a.m. ET.

Who will represent Amgen at the conference?

Peter Griffith and Paul Burton will represent Amgen.

Where can I watch the Amgen conference presentation?

The presentation will be streamed live on Amgen's website.

How long will the conference webcast be available for replay?

The webcast will be archived for at least 90 days after the event.

What is Amgen's focus in biotechnology?

Amgen focuses on developing innovative therapies for serious illnesses.

Last updated: Feb 29, 2024